Selective serotonin reuptake inhibitors: New hope in the fight against COVID-19

The emerging COVID-19 pandemic led to a dramatic increase in global mortality and morbidity rates. As in most infections, fatal complications of coronavirus affliction are triggered by an untrammeled host inflammatory response. Cytokine storms created by high levels of interleukin and other cytokine...

Descripción completa

Detalles Bibliográficos
Autores principales: Asadi Anar, Mahsa, Foroughi, Elaheh, Sohrabi, Elika, Peiravi, Samira, Tavakoli, Yasaman, Kameli Khouzani, Mozhgan, Behshood, Parisa, Shamshiri, Melika, Faridzadeh, Arezoo, Keylani, Kimia, Langari, Seyedeh Faride, Ansari, Akram, Khalaji, Amirmohammad, Garousi, Setareh, Mottahedi, Mehran, Honari, Sara, Deravi, Niloofar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748354/
https://www.ncbi.nlm.nih.gov/pubmed/36532776
http://dx.doi.org/10.3389/fphar.2022.1036093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748354/
https://www.ncbi.nlm.nih.gov/pubmed/36532776
http://dx.doi.org/10.3389/fphar.2022.1036093

Ejemplares similares